Answers are grounded in this paper and cite their sources.
Asymmetric synthesis achieved high yields of β-branched D-amino acids, indicating their potential in pharmaceuticals.
The synthesis of non-canonical amino acids (ncAAs) has recently made tremendous progress in the field of biocatalysis, with enzymes such as transaminases, dehydrogenases, and ammonia lyases being used. Frameworks of β-branched aromatic D-amino acids are crucial for the efficacy of pharmaceuticals, influencing spatial conformation, binding modes with receptors and pharmacokinetic properties. However, there is a scarcity of studies on the efficient synthesis of β-branched D-amino acids, which has significantly hindered the advancement of structure-activity relationship (SAR) studies. Here, we present the asymmetric synthesis of β-branched aromatic D-amino acid analogues catalyzed by PLP-dependent transaminase BsDAAT (from Bacillus sp. strain YM-1), an efficient transamination system that relies on the dynamic kinetic resolution (DKR) process. Through docking analysis and concise enzyme engineering, we successfully obtain various aromatic D-amino acids with β-substitution in high yields (up to 99%), dr ratios (>20:1) and ee values (up to 99%). These β-branched aromatic D-amino acids are then successfully introduced into the modifications of the antineoplastic reagent Lanreotide. Frameworks of β-branched aromatic D-amino acids are crucial for the efficacy of pharmaceuticals, but the synthesis of such scaffolds remained undeveloped. Here, authors present the first asymmetric synthesis of β-branched aromatic D-amino acid analogues via the transaminase BsDAAT catalyzed dynamic kinetic resolution (DKR) process.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: